-
Signature
-
/s/ Christopher Krueger, as Attorney-in-Fact
-
Stock symbol
-
VTYX
-
Transactions as of
-
Jun 9, 2022
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
6/10/2022, 05:40 PM
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
VTYX |
Stock Option (right to buy) |
Award |
$0 |
+13.3K |
|
$0.00 |
13.3K |
Jun 9, 2022 |
Common Stock |
13.3K |
$16.54 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Dr. Gaster is a partner of venBio Global Strategic GP III, L.P. and is a member of the board of directors of the Issuer. These options are held by Dr. Gaster for the benefit of venBio Global Strategic Fund III, L.P. ("venBio III"). Pursuant to policies of venBio Partners, the manager of venBio III, with respect to director compensation, upon the exercise of these options and sale of the underlying securities, the proceeds will be remitted to venBio III. Dr. Gaster disclaims beneficial ownership over the shares underlying the options held for the benefit of venBio III, and the filing of this Form 4 shall not be deemed an admission of beneficial ownership for purposes of Section 16 of the Securities and Exchange Act of 1934 or any other purpose.